Atrial Fibrillation Clinical Trial
Official title:
Effects of Left Atrial Appendage Occlusion
The proposed work seeks to further understand the effects of LAA occlusion on cardiac
structure and function, and in homeostasis.
Numerous studies have implicated the left atrial appendage (LAA) as the source of the vast
majority of left atrial thrombi in the setting of AF3.
The University of Pittsburgh Medical Center will be implanting a Left Atrial Appendage
filter system (the WATCHMAN® Left Atrial Appendage Filter System, manufactured by Atritech,
Inc.). We aim to follow these patients for six months post implant in order to assess their
heart rhythm, function, and to do blood tests to evaluate for neurohormonal changes.
Atrial fibrillation (AF), a heart rhythm disorder, is a major health problem. As many as 3
million US persons are afflicted; this number is expected to rise significantly in coming
decades because AF incidence is directly correlated with age1. AF is significantly
associated with cardiovascular morbidity and mortality.
The University of Pittsburgh Medical Center will be implanting a Left Atrial Appendage
filter system (the WATCHMAN® Left Atrial Appendage Filter System, manufactured by Atritech,
Inc.). We aim to follow these patients for six months post implant in order to assess:
1. Blood tests to monitor biochemical markers of cardiac remodeling and indices of heart
function. We will assess atrial natriuretic factor; brain natriuretic peptide;
norepinephrine; matrix metalloproteinases 1, 2, 3, 8, 9, and 13; gelatinases 2 and 9;
soluble tumor necrotic factor-II; angiotensin; aldosterone; ADH; rennin; interleukin-6;
TNF-α; homocysteine; C-reactive protein; quantitative D-dimer; fibrin; fibrinogen; and
fibrin split products. Biochemical markers of cardiac remodeling are being intensively
studied globally, with novel markers discovered and published frequently. Serum will be
banked for the duration of the study to allow for retrospective investigation of newly
published markers.
2. Echocardiogram to evaluate myocardial function and atrial work.
3. 24 hour holter monitor to evaluate the subjects' heart rhythm for presence or absence
of atrial fibrillation.
This study will be a non-blinded observational study with a control group. Subjects will be
recruited from the patient pool of the Principal Investigator and Co-Investigators. All
subjects in the intervention group will have had the WATCHMAN device implanted at UPMC. The
control group in this trial will be comprised of age-matched controls from the control group
in the WATCHMAN device trial, also from the patient pool of the Principal Investigator and
Co-Investigators. Subjects will be approached by one of the Investigators.
The primary outcome of interest will be left atrial work, measured on a continuous scale.
Analysis of covariance (ANCOVA) will be used to compare mean left atrial work scores at 12
months between the intervention and non-intervention patient groups adjusting for baseline
values.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |